Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 105

1.

A new model for predicting breast cancer risk in women with atypical hyperplasia.

Pankratz VS, Winham SJ, Dupont WD, Vierkant RA, Frank RD, Frost MH, Vachon C, Ghosh K, Hieken TJ, Carter JM, Haddad TC, Denison L, Visscher DW, Hartmann LC, Radisky DC.

J Clin Oncol. 2015 Oct;33(28_suppl):2. doi: 10.1200/jco.2015.33.28_suppl.2.

PMID:
28147773
2.

Cognitive Function in a Randomized Trial of Evolocumab.

Giugliano RP, Mach F, Zavitz K, Kurtz C, Im K, Kanevsky E, Schneider J, Wang H, Keech A, Pedersen TR, Sabatine MS, Sever PS, Robinson JG, Honarpour N, Wasserman SM, Ott BR; EBBINGHAUS Investigators.

N Engl J Med. 2017 Aug 17;377(7):633-643. doi: 10.1056/NEJMoa1701131.

PMID:
28813214
3.

A Phase 2 Randomized Controlled Study of Tralokinumab in Subjects with Idiopathic Pulmonary Fibrosis.

Parker JM, Glaspole IN, Lancaster LH, Haddad TJ, She D, Roseti SL, Fiening JP, Grant EP, Kell CM, Flaherty KR.

Am J Respir Crit Care Med. 2017 Aug 8. doi: 10.1164/rccm.201704-0784OC. [Epub ahead of print]

PMID:
28787186
4.

Evacetrapib and Cardiovascular Outcomes in High-Risk Vascular Disease.

Lincoff AM, Nicholls SJ, Riesmeyer JS, Barter PJ, Brewer HB, Fox KAA, Gibson CM, Granger C, Menon V, Montalescot G, Rader D, Tall AR, McErlean E, Wolski K, Ruotolo G, Vangerow B, Weerakkody G, Goodman SG, Conde D, McGuire DK, Nicolau JC, Leiva-Pons JL, Pesant Y, Li W, Kandath D, Kouz S, Tahirkheli N, Mason D, Nissen SE; ACCELERATE Investigators.

N Engl J Med. 2017 May 18;376(20):1933-1942. doi: 10.1056/NEJMoa1609581.

PMID:
28514624
5.

Impact of treatment regimen on acute care use during and after adjuvant chemotherapy for early-stage breast cancer.

Ruddy KJ, Van Houten HK, Sangaralingham LR, Freedman RA, Thompson CA, Hashmi SK, Jemal A, Haddad TC, Mougalian S, Herrin J, Gross C, Shah N.

Breast Cancer Res Treat. 2017 Aug;164(3):515-525. doi: 10.1007/s10549-017-4280-y. Epub 2017 May 10. Review.

PMID:
28493045
6.

A phase I study of cilengitide and paclitaxel in patients with advanced solid tumors.

Haddad T, Qin R, Lupu R, Satele D, Eadens M, Goetz MP, Erlichman C, Molina J.

Cancer Chemother Pharmacol. 2017 Jun;79(6):1221-1227. doi: 10.1007/s00280-017-3322-9. Epub 2017 May 5.

PMID:
28477227
7.

Tuberculous Empyema Post Bilateral Lung Transplant.

Makdisi G, Haddad TJ, Makdisi PB, Bittner HB.

Ann Thorac Surg. 2017 May;103(5):e419-e421. doi: 10.1016/j.athoracsur.2016.10.071.

PMID:
28431715
8.

In silico assessment of biomedical products: The conundrum of rare but not so rare events in two case studies.

Viceconti M, Cobelli C, Haddad T, Himes A, Kovatchev B, Palmer M.

Proc Inst Mech Eng H. 2017 May;231(5):455-466. doi: 10.1177/0954411917702931.

PMID:
28427321
9.

A phase II study of combined ridaforolimus and dalotuzumab compared with exemestane in patients with estrogen receptor-positive breast cancer.

Baselga J, Morales SM, Awada A, Blum JL, Tan AR, Ewertz M, Cortes J, Moy B, Ruddy KJ, Haddad T, Ciruelos EM, Vuylsteke P, Ebbinghaus S, Im E, Eaton L, Pathiraja K, Gause C, Mauro D, Jones MB, Rugo HS.

Breast Cancer Res Treat. 2017 Jun;163(3):535-544. doi: 10.1007/s10549-017-4199-3. Epub 2017 Mar 21.

PMID:
28324268
10.

Cardiovascular Efficacy and Safety of Bococizumab in High-Risk Patients.

Ridker PM, Revkin J, Amarenco P, Brunell R, Curto M, Civeira F, Flather M, Glynn RJ, Gregoire J, Jukema JW, Karpov Y, Kastelein JJP, Koenig W, Lorenzatti A, Manga P, Masiukiewicz U, Miller M, Mosterd A, Murin J, Nicolau JC, Nissen S, Ponikowski P, Santos RD, Schwartz PF, Soran H, White H, Wright RS, Vrablik M, Yunis C, Shear CL, Tardif JC; SPIRE Cardiovascular Outcome Investigators.

N Engl J Med. 2017 Apr 20;376(16):1527-1539. doi: 10.1056/NEJMoa1701488. Epub 2017 Mar 17.

PMID:
28304242
11.

Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease.

Sabatine MS, Giugliano RP, Keech AC, Honarpour N, Wiviott SD, Murphy SA, Kuder JF, Wang H, Liu T, Wasserman SM, Sever PS, Pedersen TR; FOURIER Steering Committee and Investigators.

N Engl J Med. 2017 May 4;376(18):1713-1722. doi: 10.1056/NEJMoa1615664. Epub 2017 Mar 17.

PMID:
28304224
12.

Incorporation of stochastic engineering models as prior information in Bayesian medical device trials.

Haddad T, Himes A, Thompson L, Irony T, Nair R; MDIC Computer Modeling and Simulation Working Group Participants.

J Biopharm Stat. 2017 Mar 10:1-15. doi: 10.1080/10543406.2017.1300907. [Epub ahead of print]

PMID:
28281931
13.

Nonclassical Size Dependence of Permeation Defines Bounds for Passive Adsorption of Large Drug Molecules.

Pye CR, Hewitt WM, Schwochert J, Haddad TD, Townsend CE, Etienne L, Lao Y, Limberakis C, Furukawa A, Mathiowetz AM, Price DA, Liras S, Lokey RS.

J Med Chem. 2017 Mar 9;60(5):1665-1672. doi: 10.1021/acs.jmedchem.6b01483. Epub 2017 Jan 25.

PMID:
28059508
14.

Using coronary calcification to exclude an ischemic etiology for cardiomyopathy: A validation study and systematic review.

Premaratne M, Shamsaei M, Chow JD, Haddad T, Erthal F, Curran H, Yam Y, Szczotka A, Mielniczuk L, Wells GA, Beanlands RS, Hossain A, Chow BJ; IMAGE-HF investigators.

Int J Cardiol. 2017 Mar 1;230:518-522. doi: 10.1016/j.ijcard.2016.12.068. Epub 2016 Dec 20.

PMID:
28041705
15.

Ticagrelor versus Clopidogrel in Symptomatic Peripheral Artery Disease.

Hiatt WR, Fowkes FG, Heizer G, Berger JS, Baumgartner I, Held P, Katona BG, Mahaffey KW, Norgren L, Jones WS, Blomster J, MillegÄrd M, Reist C, Patel MR; EUCLID Trial Steering Committee and Investigators.

N Engl J Med. 2017 Jan 5;376(1):32-40. doi: 10.1056/NEJMoa1611688. Epub 2016 Nov 13.

16.

Role of B-Type Natriuretic Peptide in Predicting In-Hospital Outcomes in Acute Exacerbation of Chronic Obstructive Pulmonary Disease With Preserved Left Ventricular Function.

Vallabhajosyula S, Haddad TM, Sundaragiri PR, Ahmed AA, Nawaz MS, Rayes HA, Devineni HC, Kanmanthareddy A, McCann DA, Wichman CS, Modrykamien AM, Morrow LE.

J Intensive Care Med. 2016 Jan 1:885066616682232. doi: 10.1177/0885066616682232. [Epub ahead of print]

PMID:
27913775
17.

Body surface mapping using an ECG belt to characterize electrical heterogeneity for different left ventricular pacing sites during cardiac resynchronization: Relationship with acute hemodynamic improvement.

Johnson WB, Vatterott PJ, Peterson MA, Bagwe S, Underwood RD, Bank AJ, Gage RM, Ramza B, Foreman BW, Splett V, Haddad T, Gillberg JM, Ghosh S.

Heart Rhythm. 2017 Mar;14(3):385-391. doi: 10.1016/j.hrthm.2016.11.017. Epub 2016 Nov 18.

PMID:
27871987
18.

Canceled coronary computed tomography angiography: Downstream testing and outcomes.

Premaratne M, Mason M, Hossain A, Haddad T, Chow JDH, Yam Y, Chow BJW.

Int J Cardiol. 2017 Jan 15;227:457-461. doi: 10.1016/j.ijcard.2016.11.011. Epub 2016 Nov 8.

PMID:
27838131
19.

Fabrication and surface modification of poly lactic acid (PLA) scaffolds with epidermal growth factor for neural tissue engineering.

Haddad T, Noel S, Liberelle B, El Ayoubi R, Ajji A, De Crescenzo G.

Biomatter. 2016 Jan;6(1):e1231276. Epub 2016 Oct 14.

20.

Acupuncture for Chemoradiation Therapy-Related Dysphagia in Head and Neck Cancer: A Pilot Randomized Sham-Controlled Trial.

Lu W, Wayne PM, Davis RB, Buring JE, Li H, Macklin EA, Lorch JH, Burke E, Haddad TC, Goguen LA, Rosenthal DS, Tishler RB, Posner MR, Haddad RI.

Oncologist. 2016 Dec;21(12):1522-1529. Epub 2016 Aug 10.

PMID:
27511906

Supplemental Content

Loading ...
Support Center